Partenaires



Rechercher

Sur ce site

Sur le Web du CNRS


Accueil du site > Équipes > Molécules Bioactives > Synthesis and development of New Bioactive Molecules. New therapeutic strategies

Synthesis and development of New Bioactive Molecules. New therapeutic strategies

Presentation

The main objective of R. Benhida group over the last years has been to develop new chemical strategies to answer several challenging questions in biology and medicine using small organic molecules. This includes : the development of new synthetic methodologies, the development of modern drug discovery programs with the application of modern medicinal chemistry, nucleic acids chemistry and chemical biology for the identification and validation of new biological targets. The team has high contribution in the identification and validation of new bioactive molecules and novel relevant targets, particularly to overcome drug resistance in oncology.

Current fields of interest

  • Development of synthetic methodologies
  • ‘Smart’ Drug discovery : Medicinal Chemistry and Chemical biology
  • Nucleic acid chemistry